清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Osteosarcoma pre-diagnosed as another tumor: a report from the Cooperative Osteosarcoma Study Group (COSS)

骨肉瘤 医学 成骨细胞瘤 软骨肉瘤 初生骨 肉瘤 骨巨细胞瘤 内科学 颅面 外科 化疗 医学诊断 放射科 病理 巨细胞 精神科
作者
Stefanie Hecker‐Nolting,Daniel Baumhoer,Claudia Blattmann,Leo Kager,Thomas Kühne,Matthias Kevric,Susanna Lang,Vanessa Mettmann,Benjamin Sorg,Matthias Werner,Stefan Bielack
出处
期刊:Journal of Cancer Research and Clinical Oncology [Springer Nature]
卷期号:149 (5): 1961-1967 被引量:4
标识
DOI:10.1007/s00432-022-04156-1
摘要

The course of osteosarcoma patients primarily treated as such has been well described. Little, however, is known about patients who were primarily treated assuming a different tumor diagnosis.The database of the Cooperative Osteosarcoma Study Group COSS was searched (4.435 primary high-grade central osteosarcomas registered prior to 01/01/21). A different tumor entity had to have been assumed for at least one month after the initial diagnostic procedure before the correct diagnosis of osteosarcoma was finally made. Identified patients were analyzed for demographic, tumor-, and treatment-related factors as well as for survival outcomes.37 patients were identified. They were a median of 19.7 (2.7-60.4) years old at first presentation and were more likely to be females than males (23:14). Bone cysts (n = 8), giant cell tumor of bone (n = 6), and osteoblastoma (n = 6) were the most frequent of 29/37 (78%) benign, chondrosarcoma and its variants (n = 6) the most frequent of 8/37 (22%) malignant original diagnoses. Tumors affected the extremities in 23 (62%), the trunk in 11 (30%), and the craniofacial bones in 3 (8%). Only one patient received systemic treatment while assuming the different diagnosis (1/37, 3%). The median time until the correct diagnosis of osteosarcoma was made was 8 months (range: 1 month-14.1 years). At that time, 6/37 (16%) presented with metastatic disease. All patients went on to receive chemotherapy, 17/37 (46%) neo-adjuvantly. Histologic response was only evaluated in 13/17 (76%) patients and was good (< 10% viable tumor) in only 4/13 (31%) patients. In 31/37 (84%) patients, a surgically complete resection of all macroscopically identified tumor manifestations could be achieved. Five-year overall and event-free survival rates at 5 years were 50.2% (standard error: 8.6%) and 42.6% (8.5%), respectively.Osteosarcoma may initially be misdiagnosed and hence subjected to inappropriate treatment including misguided surgery. Once diagnosed correctly, some of the affected patients may still be cured if finally treated according to modern osteosarcoma standards.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
5秒前
MYC007完成签到 ,获得积分10
13秒前
希达通完成签到 ,获得积分10
26秒前
sweet雪儿妞妞完成签到 ,获得积分10
27秒前
爱学习的小可关注了科研通微信公众号
29秒前
30秒前
极限地带完成签到 ,获得积分10
31秒前
阳光铭媚发布了新的文献求助10
36秒前
36秒前
ranan发布了新的文献求助10
38秒前
朱文韬发布了新的文献求助10
42秒前
42秒前
Arlene完成签到 ,获得积分10
45秒前
科研通AI6.3应助阳光铭媚采纳,获得10
48秒前
wh1t3zZ发布了新的文献求助10
48秒前
50秒前
SaulXu发布了新的文献求助10
54秒前
爆米花应助ranan采纳,获得10
1分钟前
1分钟前
博姐37完成签到 ,获得积分10
1分钟前
李文达发布了新的文献求助10
1分钟前
1分钟前
1分钟前
珺宸发布了新的文献求助10
1分钟前
闻巷雨完成签到 ,获得积分10
1分钟前
北枳完成签到,获得积分10
1分钟前
李文达完成签到,获得积分10
1分钟前
feiyafei完成签到 ,获得积分10
1分钟前
fluttershy完成签到 ,获得积分10
1分钟前
Ava应助珺宸采纳,获得10
1分钟前
玛琳卡迪马完成签到,获得积分10
1分钟前
SaulXu完成签到,获得积分10
1分钟前
zhuosht完成签到 ,获得积分10
1分钟前
搬砖王完成签到,获得积分10
1分钟前
左丘映易完成签到,获得积分10
1分钟前
小白完成签到 ,获得积分10
1分钟前
ling361完成签到,获得积分0
2分钟前
香菜张完成签到,获得积分10
2分钟前
我是老大应助WJZ采纳,获得20
2分钟前
时老完成签到 ,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
First commercial application of ELCRES™ HTV150A film in Nichicon capacitors for AC-DC inverters: SABIC at PCIM Europe 1000
Feldspar inclusion dating of ceramics and burnt stones 1000
Digital and Social Media Marketing 600
Zeolites: From Fundamentals to Emerging Applications 600
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5988621
求助须知:如何正确求助?哪些是违规求助? 7420603
关于积分的说明 16049953
捐赠科研通 5129803
什么是DOI,文献DOI怎么找? 2752172
邀请新用户注册赠送积分活动 1724186
关于科研通互助平台的介绍 1627520